JILL CARROLL

Jill Carroll is a distinguished Principal at SR One, a premier independent venture capital firm with a rich history of investing in transformative life sciences companies. At SR One, Jill plays a pivotal role in identifying, evaluating, and nurturing promising early stage and growth stage ventures across the biotechnology and broader healthcare landscape. Her work is instrumental in SR One's mission to back innovative science and technology that addresses significant unmet medical needs.

Jill's investment focus areas are broad within life sciences, encompassing novel therapeutics, cutting edge diagnostics, innovative medical devices, and disruptive digital health solutions. She is particularly interested in companies leveraging breakthrough scientific discoveries to develop first in class or best in class products. Her approach involves deep scientific diligence combined with a keen understanding of market dynamics and commercial potential, ensuring that SR One's investments are strategically positioned for long term success and impact.

While specific details of Jill Carroll's career background are not publicly detailed, professionals in her role at SR One typically possess a robust foundation in science, medicine, or a related technical field, often complemented by significant experience in venture capital, corporate development, or pharmaceutical R&D. This blend of scientific acumen and business expertise allows her to effectively assess complex scientific platforms and translate them into viable investment opportunities. Her background likely includes a strong track record of identifying emerging trends and technologies that have the potential to reshape healthcare.

Though individual notable investments are often attributed to the firm as a whole, Jill Carroll is actively involved in SR One's portfolio management, contributing to the strategic growth and development of its invested companies. She works closely with founders and management teams, providing guidance and leveraging SR One's extensive network to accelerate company progress. Her contributions help these innovative companies navigate the challenging path from concept to commercialization, ultimately bringing new solutions to patients worldwide. Jill Carroll's dedication to advancing life sciences innovation makes her a key figure in the venture capital ecosystem.